| scholarly article | Q13442814 |
| P50 | author | Christelle Harly | Q63389851 |
| Cassie-Marie Peigné | Q87969323 | ||
| Julie Déchanet-Merville | Q100940387 | ||
| Marc Bonneville | Q108917373 | ||
| Sonia Netzer | Q117248453 | ||
| Steven Nedellec | Q117248454 | ||
| Alexandra Léger | Q117248455 | ||
| Richard Breathnach | Q117248456 | ||
| Thomas Herrmann | Q42215037 | ||
| Emmanuel Scotet | Q58668606 | ||
| P2093 | author name string | Daniel Olive | |
| Erin J Adams | |||
| Jianqiang Li | |||
| Jukka Mönkkönen | |||
| Jürgen Kuball | |||
| Hannu Mönkkönen | |||
| Yves Guillaume | |||
| P2860 | cites work | CD28/B7 system of T cell costimulation | Q24313544 |
| Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells | Q24336997 | ||
| Differential role for CD277 as a co-regulator of the immune signal in T and NK cells | Q24337928 | ||
| Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists | Q24673582 | ||
| Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function | Q24684586 | ||
| Structure of a human gammadelta T-cell antigen receptor | Q27633359 | ||
| Structure and evolution of the extended B7 family | Q28198042 | ||
| Gamma/delta T-cell stimulation by pamidronate | Q74587506 | ||
| Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I | Q81304839 | ||
| Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity | Q84541338 | ||
| The cluster of BTN genes in the extended major histocompatibility complex | Q28199806 | ||
| BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation | Q28506887 | ||
| Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells | Q28581860 | ||
| Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells | Q28584831 | ||
| Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells | Q28587448 | ||
| Skint-1 is a highly specific, unique selecting component for epidermal T cells | Q28592602 | ||
| Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. | Q33718867 | ||
| Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection | Q33904052 | ||
| Identification of (E)‐4‐hydroxy‐3‐methyl‐but‐2‐enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli | Q34104852 | ||
| CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells | Q34352531 | ||
| Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs | Q34749889 | ||
| Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells | Q36370502 | ||
| Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors | Q36548005 | ||
| Antigen recognition by gammadelta T cells | Q36732651 | ||
| Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens | Q36732656 | ||
| Photoaffinity antigens for human gammadelta T cells | Q37226687 | ||
| Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. | Q37344573 | ||
| The PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase: implications for the function of BTN1A1 in the mammary gland and other tissues | Q37372311 | ||
| Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity | Q37764294 | ||
| gammadelta T cells in cancer immunotherapy: current status and future prospects | Q37773286 | ||
| A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. | Q38756878 | ||
| Redirecting αβ T cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor | Q39544028 | ||
| NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals. | Q39698695 | ||
| The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. | Q40271774 | ||
| Contrasting contributions of complementarity-determining region 2 and hypervariable region 4 of rat BV8S2+ (Vbeta8.2) TCR to the recognition of myelin basic protein and different types of bacterial superantigens | Q40564808 | ||
| Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells | Q41029784 | ||
| Stimulation of gamma delta T cells by phosphoantigens. | Q41171464 | ||
| Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. | Q41289959 | ||
| Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. | Q41346251 | ||
| Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. | Q42485819 | ||
| Peripheral selection of antigen receptor junctional features in a major human gamma delta subset | Q42615935 | ||
| F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for Vgamma9Vdelta2 T cells | Q43059671 | ||
| Gammadelta T cells and the lymphoid stress-surveillance response | Q43496487 | ||
| Recognition mechanism of non-peptide antigens by human gammadelta T cells | Q44622855 | ||
| Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation | Q46902168 | ||
| Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells | Q51890695 | ||
| A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes | Q53438021 | ||
| Selection of the cutaneous intraepithelial γδ+ T cell repertoire by a thymic stromal determinant | Q60241792 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| Butyrophilin subfamily 3 member A3 | Q21112858 | ||
| Butyrophilin subfamily 3 member A2 | Q21112864 | ||
| P304 | page(s) | 2269-2279 | |
| P577 | publication date | 2012-07-05 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset | |
| P478 | volume | 120 |
| Q36410082 | A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1. |
| Q28829233 | A Subset of Protective γ9δ2 T Cells Is Activated by Novel Mycobacterial Glycolipid Components |
| Q52731753 | A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells. |
| Q39008018 | A fat story-antigen presentation by butyrophilin 3A1 to γδ T cells |
| Q58543705 | A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigens |
| Q55339238 | ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells. |
| Q97420850 | Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity |
| Q90398665 | Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes |
| Q28256238 | Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin |
| Q90090369 | Alpaca (Vicugna pacos), the first nonprimate species with a phosphoantigen-reactive Vγ9Vδ2 T cell subset |
| Q38798990 | Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells |
| Q90616712 | An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer |
| Q92438871 | Analysis of macaque BTN3A genes and transcripts in the extended MHC: conserved orthologs of human γδ T cell modulators |
| Q33920919 | Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug |
| Q38149725 | At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies |
| Q38151057 | At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias |
| Q50034000 | Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor. |
| Q50420977 | BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC). |
| Q37380386 | BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia |
| Q40070853 | BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain |
| Q46353639 | BTN3A1-antibodies and phosphoantigens: TCRVγ9Vδ2 "see" the difference. |
| Q97644517 | Bibliometrics Analysis of Butyrophilins as Immune Regulators [1992-2019] and Implications for Cancer Prognosis |
| Q38848635 | Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation |
| Q48359042 | Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. |
| Q27685257 | Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells |
| Q28660812 | Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells |
| Q39029042 | Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system |
| Q28505371 | Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes |
| Q90187881 | Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing |
| Q64079825 | Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma |
| Q98158662 | Butyrophilin-like proteins display combinatorial diversity in selecting and maintaining signature intraepithelial γδ T cell compartments |
| Q54268399 | Butyrophilin3A proteins and Vγ9Vδ2 T cell activation. |
| Q50308633 | Butyrophilins: an important new element of resistance |
| Q48124547 | CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells. |
| Q84972152 | CD277 takes the lead in human γδ T-cell activation |
| Q48331916 | CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells |
| Q38283536 | Cancer Immunotherapy Using γδT Cells: Dealing with Diversity |
| Q97653023 | Cancer immunotherapy with γδ T cells: many paths ahead of us |
| Q27312069 | Characterization of a Putative Receptor Binding Surface on Skint-1, a Critical Determinant of Dendritic Epidermal T Cell Selection. |
| Q47146669 | Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells |
| Q98465659 | Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells |
| Q39028978 | Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells |
| Q47100174 | Current Advances in γδ T Cell-Based Tumor Immunotherapy |
| Q40207403 | Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells. |
| Q39092574 | Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma |
| Q27026152 | Defining the nature of human γδ T cells: a biographical sketch of the highly empathetic |
| Q59137745 | Dendritic Cells Are Critical for the Activation and Expansion of Vδ2 T Cells After Allogeneic Hematopoietic Transplantation |
| Q90259222 | Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire |
| Q64103902 | Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B |
| Q50550722 | Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer |
| Q46169443 | Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities |
| Q55049680 | Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate |
| Q52367095 | Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy |
| Q26800118 | Early innate responses to pathogens: pattern recognition by unconventional human T-cells |
| Q41061926 | Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives". |
| Q54626514 | Editorial: Vγ9Vδ2 T cells: triple costimulation goes the distance |
| Q93109123 | Emerging role of γδ T cells in vaccine-mediated protection from infectious diseases |
| Q90044346 | Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors |
| Q37655345 | Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation |
| Q37285138 | Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments |
| Q64103688 | Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells |
| Q35739148 | Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public |
| Q36337551 | Evolutionary and polymorphism analyses reveal the central role of BTN3A2 in the concerted evolution of the BTN3 gene family |
| Q33938500 | Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions. |
| Q47666620 | Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug |
| Q55223108 | Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. |
| Q98735518 | Get in Touch With Dendritic Epithelial T Cells! |
| Q34395668 | HIV infection of monocytes-derived dendritic cells inhibits Vγ9Vδ2 T cells functions |
| Q37072016 | HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors |
| Q27027547 | Harnessing the power of Vδ2 cells in cancer immunotherapy |
| Q37515155 | Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals |
| Q48232215 | Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology |
| Q41613391 | Human Vδ2(+) γδ T Cells Differentially Induce Maturation, Cytokine Production, and Alloreactive T Cell Stimulation by Dendritic Cells and B Cells. |
| Q35738915 | Human gamma delta T cells: Evolution and ligand recognition |
| Q89794792 | Human unconventional T cells in Plasmodium falciparum infection |
| Q90737012 | Human γδ TCR Repertoires in Health and Disease |
| Q37714642 | Human γδT-cell subsets and their involvement in tumor immunity. |
| Q38171917 | Hunting for clinical translation with innate-like immune cells and their receptors |
| Q38233770 | Immune modulation by butyrophilins |
| Q39397758 | Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins |
| Q55311835 | Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer |
| Q53008599 | Inhibition of human γδ T cell proliferation and effector functions by neutrophil serine proteases |
| Q28085321 | Innate-like lymphocytes in intestinal infections |
| Q52716912 | Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion. |
| Q97692776 | Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions |
| Q88550356 | Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model |
| Q38951790 | Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy |
| Q34560345 | Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. |
| Q47105437 | Mevalonate Metabolism in Immuno-Oncology |
| Q46592108 | Mevalonate metabolism governs cancer immune surveillance. |
| Q34218508 | Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells |
| Q49838268 | Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand |
| Q55237064 | Molecular Determinants of Target Cell Recognition by Human γδ T Cells |
| Q34819275 | Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells |
| Q49333274 | NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT). |
| Q39798606 | NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors |
| Q53235682 | Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape |
| Q54691443 | Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells. |
| Q90534741 | New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity |
| Q27007035 | Nonclassical T cells and their antigens in tuberculosis |
| Q88698476 | Peripheral clonal selection shapes the human γδ T-cell repertoire |
| Q38715641 | Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism. |
| Q36053510 | Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vγ9Vδ2 T Cells |
| Q34970077 | Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones |
| Q40093467 | Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation |
| Q34652408 | Plasticity of γδ T Cells: Impact on the Anti-Tumor Response |
| Q57300020 | Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression |
| Q48104723 | Prediction of Disordered Regions and Their Roles in the Anti-Pathogenic and Immunomodulatory Functions of Butyrophilins. |
| Q38728528 | Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody. |
| Q38890450 | Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy. |
| Q57024595 | Protective Role of T Cells in Different Pathogen Infections and Its Potential Clinical Application |
| Q52313512 | Recasting Human Vδ1 Lymphocytes in an Adaptive Role. |
| Q94602404 | Recent advances in understanding the development and function of γδ T cells |
| Q26823185 | Regeneration of stalled immune responses to transformed and infected cells using γδ T cells |
| Q52718401 | Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters. |
| Q92405201 | Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells |
| Q88008277 | Regulatory functions of γδ T cells |
| Q47744427 | Resolving the mystery of pyrophosphate antigen presentation |
| Q90521943 | Revisiting the Interaction of γδ T-Cells and B-Cells |
| Q37279963 | RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor |
| Q34482936 | Role of Innate T Cells in Anti-Bacterial Immunity |
| Q35000371 | Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells. |
| Q37730154 | Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2. |
| Q36845046 | Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells |
| Q49834319 | Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease |
| Q33716835 | Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns |
| Q92225913 | Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes |
| Q27010451 | Six-of-the-best: unique contributions of γδ T cells to immunology |
| Q92937452 | Stability and Efficiency of Mixed Aryl Phosphonate Prodrugs |
| Q37079078 | Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors. |
| Q40953833 | Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism. |
| Q95847211 | Structure-Activity Relationships of Butyrophilin 3 Ligands |
| Q92946519 | Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength |
| Q90151422 | Synthesis and Bioactivity of the Alanyl Phosphonamidate Stereoisomers Derived from a Butyrophilin Ligand |
| Q49849833 | Synthesis and Biological Evaluation of (E)-4-Hydroxy-3-Methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cells Immune Response. |
| Q62735455 | Synthesis and Immunomodulatory Activity of Fluorine-Containing Bisphosphonates |
| Q38398684 | T lymphocyte regulation by mevalonate metabolism. |
| Q92285876 | TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product |
| Q89542447 | TEG011 persistence averts extramedullary tumor growth without exerting off-target toxicity against healthy tissues in a humanized HLA-A*24:02 transgenic mice |
| Q90290705 | TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells |
| Q42211743 | The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells. |
| Q53838399 | The Armadillo (Dasypus novemcinctus): A Witness but Not a Functional Example for the Emergence of the Butyrophilin 3/Vγ9Vδ2 System in Placental Mammals |
| Q27682926 | The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells |
| Q27670973 | The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies |
| Q28069991 | The Role of γδ T Cells in Fibrotic Diseases |
| Q34741552 | The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells |
| Q50892187 | The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region |
| Q52714460 | The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets |
| Q27677529 | The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins |
| Q26859775 | The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy |
| Q36584814 | The role of B7 family molecules in hematologic malignancy |
| Q43551303 | The role of bovine γδ T cells and their WC1 co-receptor in response to bacterial pathogens and promoting vaccine efficacy: a model for cattle and humans |
| Q60241510 | The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness |
| Q59806979 | Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells |
| Q54219852 | Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells. |
| Q93162748 | Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies |
| Q42086300 | Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors |
| Q35245316 | Tumor necrosis factor superfamily in innate immunity and inflammation |
| Q38287973 | Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment. |
| Q85759121 | Tumor-killing γδ-TCRs take center stage |
| Q40216780 | Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells. |
| Q37229095 | Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling. |
| Q92000263 | Vitamin C supports conversion of human γδ T cells into FOXP3-expressing regulatory cells by epigenetic regulation |
| Q42237075 | Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). |
| Q98177693 | Vγ9Vδ2 T Cells Activation Through Phosphoantigens Can Be Impaired by a RHOB Rerouting in Lung Cancer |
| Q90259195 | Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression |
| Q40150564 | Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens. |
| Q42214986 | Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6. |
| Q34936375 | Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. |
| Q43919237 | Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis) |
| Q39424529 | What Else Can CD39 Tell Us? |
| Q38809547 | What rheumatologists need to know about innate lymphocytes |
| Q55019451 | Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells |
| Q40252845 | Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity. |
| Q38986536 | Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing |
| Q40213985 | Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner. |
| Q26995102 | γδ T Cell Immunotherapy-A Review |
| Q89747000 | γδ T Cells Kill Plasmodium falciparum in a Granzyme- and Granulysin-Dependent Mechanism during the Late Blood Stage |
| Q58572524 | γδ T Cells in Antimalarial Immunity: New Insights Into Their Diverse Functions in Protection and Tolerance |
| Q28084822 | γδ T Cells in HIV Disease: Past, Present, and Future |
| Q37576001 | γδ T cells and their potential for immunotherapy |
| Q38602555 | γδ T cells in cancer |
| Q100560002 | γδ T cells in tissue physiology and surveillance |
| Q92826000 | γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer |
| Q44208447 | γδ T-cell conference 2012: close encounters for the fifth time |
| Q91142947 | γδ TCR ligands: the quest to solve a 500-million-year-old mystery |
| Q38271585 | γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy |
Search more.